Riskpilot← Back to searchSign inGet full accessRe:habit AB
ABActiveOrg 5591092480Tyllsnäsvägen 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20171-4 employees
Revenue 2025
SEK 17,6M
+42% vs 2024
EBITDA margin
-10.9%
-1773% vs 2024
Equity ratio
-59.4%
Financial strength
Net profit 2025
SEK -2M
-65899% vs 2024
| Revenue | SEK 17,6M | +42% |
| EBITDA | SEK -1,9M | -1773% |
| Net profit | SEK -2M | -65899% |
| Total assets | SEK 2,9M | -29% |
| Equity | SEK -1,7M | -652% |
| Employees | — | — |
Legal name
Re:habit AB
Org number
5591092480
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
19 april 2017
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Import och försäljning av ortopediska hjälpmedel för rehabilitering av människokroppen.
Address
Tyllsnäsvägen 4
Email
arvid@rehabit.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 060 | 8 819 | 10 948 | 12 430 | 17 609 |
| Staff expenses | — | −1 151 | −1 085 | −1 941 | −2 929 |
| EBITDA | 661 | 704 | 366 | −102 | −1 918 |
| Depreciation & amort. | −5 | −14 | −24 | −26 | −65 |
| EBIT | 656 | 690 | 342 | −128 | −1 983 |
| Net financials | −17 | −10 | −36 | −56 | −146 |
| Profit before tax | 524 | 511 | 308 | 10 | −2 042 |
| Tax | −63 | −103 | −66 | −7 | — |
| Net profit | 461 | 408 | 242 | 3 | −2 042 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 643 | 1 881 | 2 274 | 4 098 | 2 910 |
| Equity | 260 | 468 | 510 | 313 | −1 729 |
| Long-term debt | 0 | — | 540 | 803 | 1 530 |
| Short-term debt | 1 268 | 1 129 | 942 | 2 895 | 3 110 |
| Total debt | 1 268 | 1 129 | 1 481 | 3 698 | 4 640 |
EBITDA margin
-10.9%
This company
15.8%
Market median
-169% vs market
20212025
Equity ratio
-59.4%
This company
38.2%
Market median
-255% vs market
20212025
Return on equity
-204240700.0%
This company
18.4%
Market median
-1110003904% vs market
20212025
Net profit margin
-11.6%
This company
8.1%
Market median
-243% vs market
20212025
Asset turnover
6.05×
This company
1.12×
Market median
+440% vs market
20212025
Debt / equity
2.68×
This company
0.62×
Market median
-332% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JU Chief Auditor | Chief Auditor | 2024 |
| Former (1) | ||
RJ Chief Auditor | Chief Auditor | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Re:habit AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ronny Joakim Karlsson | Chief Auditor | 0 companies |
| Jenny Ulrika Barksjö Forslund | Chief Auditor | 0 companies |
| Hans Per Viktor Forsman | Deputy Board Member | 0 companies |
| Hans Per Arvid Forsman | Board of Directors | 0 companies |